Results 21 to 30 of about 22,462 (308)
Radiopharmaceuticals in cardiology
Myocardial perfusion studies are among the most often performed investigations in Nuclear Medicine. However, the development of radiopharmaceuticals for cardiology is an emerging discipline and several other radiotracers have been proven to be useful.
Piotr Garnuszek, Renata Mikolajczak
openaire +4 more sources
The application of bacterial endotoxin test (BET) using TAL reagent on radiopharmaceutical kits is very important to conduct. The radiopharmaceutical kits that will be tested are macro aggregated albumin (MAA), tetrofosmin and ethambutol kits.
Amal Rezka Putra+5 more
doaj +1 more source
Simulating Araponga -- The High-Resolution Diffractometer of Brazilian Multipurpose Reactor [PDF]
The Brazilian Multipurpose Reactor (RMB) is a fundamental project that aims to turn Brazil into a self-sufficient country in the production of radioisotopes and radiopharmaceuticals to supply the Unified Health System (SUS) as much as the private institutions.
arxiv +1 more source
Purpose The angiotensin converting enzyme-2 (ACE2)—entry receptor of SARS-CoV-2—and its homologue, the angiotensin-converting enzyme (ACE), play a pivotal role in maintaining cardiovascular homeostasis.
Darja Beyer+12 more
doaj +1 more source
Reproducibility of 3 T APT‐CEST in Healthy Volunteers and Patients With Brain Glioma
Background Amide proton transfer (APT) imaging is a chemical exchange saturation transfer (CEST) technique offering potential clinical applications such as diagnosis, characterization, and treatment planning and monitoring in glioma patients. While APT‐CEST has demonstrated high potential, reproducibility remains underexplored.
Ivar J.H.G. Wamelink+8 more
wiley +1 more source
68Ga‐nitroimidazole PET/CT imaging of hypoxia in tuberculosis: A case series
There is increasing application of PET/CT imaging in infectious diseases such as tuberculosis. Imaging potential stressors such as hypoxia, using a novel Ga‐68 labelled hypoxia seeking agent, has the potential to identify patients who may benefit from individualised treatment strategies.
Philippa L Bresser+3 more
wiley +1 more source
PET has experienced exponential growth over the last few decades in terms of innovative technologies and novel radiopharmaceuticals. This has fostered increasing collaboration between radiographers and nuclear medicine technologists. Abstract Positron emission tomography (PET) as an imaging modality has undergone considerable innovation over the past ...
Sally L. Ayesa, Andrew Murphy
wiley +1 more source
New results on proton-induced reactions on Vanadium for $^{47}$Sc production and the impact of level densities on theoretical cross sections [PDF]
New data for the $^\mbox{nat}$V(p,x) reactions have been measured in the range 26-70 MeV, with production of the nuclides $^{47}$Sc, $^{43}$Sc, $^{44m}$Sc, $^{44g}$Sc, $^{46}$Sc, $^{48}$Sc, $^{42}$K, $^{43}$K, $^{48}$V, $^{48}$Cr, $^{49}$Cr, and $^{51}$Cr.
arxiv +1 more source
Adjuvant Drug-Assisted Bone Healing: Advances and Challenges in Drug Delivery Approaches
Bone defects of critical size after compound fractures, infections, or tumor resections are a challenge in treatment. Particularly, this applies to bone defects in patients with impaired bone healing due to frequently occurring metabolic diseases (above ...
Rebecca Rothe+6 more
doaj +1 more source
Background Chimeric antigen receptor (CAR) T-cells are a promising approach in cancer immunotherapy, particularly for treating hematologic malignancies.
Liliana R. Loureiro+11 more
doaj +1 more source